Hereditary hemochromatosis

Postgraduate Medicine
|December 9, 2017
PubMed

Insights

Hereditary hemochromatosis affects 1 in 250-300 people of northern European descent. Early diagnosis and treatment of this iron overload disorder lead to a good prognosis, preventing serious complications.

Area of Science:

  • Genetics
  • Gastroenterology
  • Internal Medicine

Background:

  • Hereditary hemochromatosis (HH) is an iron overload disorder.
  • Previously considered rare, HH now affects 1 in 250-300 individuals of northern European ancestry.
  • Untreated HH can lead to severe health complications.

Purpose of the Study:

  • To provide a guide for the diagnosis and management of hereditary hemochromatosis.
  • To outline screening protocols, diagnostic tests, and treatment strategies.
  • To discuss the impact of early intervention on patient prognosis and complications.

Main Methods:

  • Review of current literature and clinical guidelines.
  • Discussion of screening criteria for at-risk populations.
  • Analysis of diagnostic testing and interpretation.
  • Evaluation of treatment modalities and their efficacy.

Main Results:

  • Hereditary hemochromatosis is more prevalent than previously thought.
  • Early detection and treatment significantly improve patient outcomes.
  • Management involves phlebotomy and monitoring of iron levels.

Conclusions:

  • Hereditary hemochromatosis is a common genetic disorder with manageable complications.
  • Timely screening, diagnosis, and treatment are crucial for a favorable prognosis.
  • This guide offers practical recommendations for clinicians managing HH patients.

Related Concept Videos

Genetic Lingo01:11

Genetic Lingo

Overview
115.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
539
X-linked Traits01:19

X-linked Traits

In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
59.0K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.4K
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
38.3K
Pedigree Analysis01:35

Pedigree Analysis

Overview
89.9K